These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33600260)

  • 1. Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.
    Zheng W; Zhang J; Song Q; Xu Y; Zhu M; Ma J
    DNA Cell Biol; 2021 Mar; 40(3):469-481. PubMed ID: 33600260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
    Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
    Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
    [No Abstract]   [Full Text] [Related]  

  • 3. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
    Shen C; Liu J; Wang J; Yang X; Niu H; Wang Y
    Dis Markers; 2020; 2020():4312629. PubMed ID: 32454905
    [No Abstract]   [Full Text] [Related]  

  • 4. Unveiling the role of RAC3 in the growth and invasion of cisplatin-resistant bladder cancer cells.
    Li H; Ma H; Ma J; Qin F; Fan S; Kong S; Zhao S; Ma J
    J Cell Mol Med; 2024 Jun; 28(11):e18473. PubMed ID: 38847477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the mRNAs associated with Bladder cancer recurrence.
    Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
    Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentially Expressed Genes in Matched Normal, Cancer, and Lymph Node Metastases Predict Clinical Outcomes in Patients With Breast Cancer.
    Kim GE; Kim NI; Lee JS; Park MH; Kang K
    Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):111-122. PubMed ID: 32044879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
    Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
    Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatic identification of prognostic indicators in bladder cancer.
    Quan J; Zhang W; Yu C; Bai Y; Cui J; Lv J; Zhang Q
    Biomark Med; 2020 Sep; 14(13):1243-1254. PubMed ID: 32749145
    [No Abstract]   [Full Text] [Related]  

  • 9. Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target.
    Yamada Y; Kato M; Arai T; Sanada H; Uchida A; Misono S; Sakamoto S; Komiya A; Ichikawa T; Seki N
    Mol Oncol; 2019 Sep; 13(9):1898-1912. PubMed ID: 31199049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel risk score based on a combined signature of 10 immune system genes to predict bladder cancer prognosis.
    Tang Y; Hu Y; Wang J; Zeng Z
    Int Immunopharmacol; 2020 Oct; 87():106851. PubMed ID: 32763782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.
    Liu L; Hu J; Wang Y; Sun T; Zhou X; Li X; Ma F
    Aging (Albany NY); 2020 Jun; 12(12):11967-11989. PubMed ID: 32570217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer.
    Yeh HC; Huang CN; Li CC; Chang LL; Lin HH; Ke HL; Huang AM; Liang PI; Li CF; Wu WJ
    World J Urol; 2016 Jun; 34(6):835-46. PubMed ID: 26433386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
    Li Q; Li C; Chen J; Liu P; Cui Y; Zhou X; Li H; Zu X
    Urol Oncol; 2018 Jun; 36(6):310.e15-310.e22. PubMed ID: 29605462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
    Tang K; Wang C; Chen Z; Xu H; Ye Z
    Int J Clin Exp Pathol; 2015; 8(5):4999-5007. PubMed ID: 26191193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
    Ning XH; Qi YY; Wang FX; Li SC; Jia ZK; Yang JJ
    Biomed Res Int; 2020; 2020():7272960. PubMed ID: 33150179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
    Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
    Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
    Wang JF; Gong YQ; He YH; Ying WW; Li XS; Zhou XF; Zhou LQ
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6605-6615. PubMed ID: 32633349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis and prognostic potential of RAC3 in bladder tumor.
    Wang S; Wei Z; Shu H; Xu Y; Fan Z; Shuang S; Li P; Lu P; Ye C
    Int Urol Nephrol; 2024 Feb; 56(2):475-482. PubMed ID: 37728806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancer.
    Zhang S; Li J; Zhou G; Mu D; Yan J; Xing J; Yao Z; Sheng H; Li D; Lv C; Sun B; Hong Q; Guo H
    Tumour Biol; 2016 Apr; 37(4):5165-70. PubMed ID: 26547586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer.
    Wang Y; Zhao S; Qin Q; Gao X; Zhang X; Zhang M; Jiang Y; Ji X; Zhu H; Zhao X; Li H
    PLoS One; 2022; 17(1):e0262000. PubMed ID: 35077462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.